The Tissue and Molecular Pathology Core (TMPC) consists of several distinct, yet highly interactive services and banks, all related to the procurement, processing and evaluation of tissue for cancer research (see Fig. below). The Tissue Procurement Service collects and distributes surplus human tissue from surgical specimens. Patients are consented for use of their tissues, which can be collected and processed in a variety of ways depending on the specific needs of the investigator. The Histology and immunohistochemistry Service provides expert histology and immunohistochemistry services. The lab uses several automated Immunohistochemistry instruments and offers complete workup of novel antibodies with various antigen retrieval protocols and titrations. The Tissue Microarray Service constructs routine and custom designed tissue microarrays to be used in immunohistochemical, immunofluorescent and in s/fu hybridization assays. The Anonymous Paraffin Bank consists of over 2500 paraffin blocks of normal tissues and tumors of all types collected from surplus surgical tissue. Tissues from this bank are used by the Core and UMCCC Investigators for all types of research activities, primarily tissue microarray construction and immunohistochemical workup of antibodies. The Laser Capture Microdissection Service assists investigators with all aspects of laser capture microdissection. The Frozen Tumor Bank collects surplus human tissue when available, and currently contains over 7500 frozen tissue samples, The Molecular Pathology Research Laboratory offers a full menu of molecular pathology assays with a focus on evaluating frozen and fixed neoplastic human tissues. Collectively, the services of the Tissue and Molecular Pathology Core provide UMCCC investigators access to a wide variety of high-quality mission-critical tissue procurement and evaluation services.
The Tissue and Molecular Pathology Core Is directly relevant to cancer research as it provides UMCCC cancer investigators access to human tissue samples and molecular pathology assays. These services generally advance cancer research by facilitating the research of many UMCCC Investigators.
|Skolarus, Ted A; Metreger, Tabitha; Hwang, Soohyun et al. (2017) Optimizing veteran-centered prostate cancer survivorship care: study protocol for a randomized controlled trial. Trials 18:181|
|Hertz, Daniel L; Speth, Kelly A; Kidwell, Kelley M et al. (2017) Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients. Breast Cancer Res Treat 165:659-668|
|Pinskey, Justine M; Franks, Nicole E; McMellen, Alexandra N et al. (2017) Neuropilin-1 promotes Hedgehog signaling through a novel cytoplasmic motif. J Biol Chem 292:15192-15204|
|Maj, Tomasz; Wang, Wei; Crespo, Joel et al. (2017) Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor. Nat Immunol 18:1332-1341|
|Zhang, Jie; Feng, Shumei; Su, Wenmei et al. (2017) Overexpression of FAM83H-AS1 indicates poor patient survival and knockdown impairs cell proliferation and invasion via MET/EGFR signaling in lung cancer. Sci Rep 7:42819|
|Mann, J E; Hoesli, R; Michmerhuizen, N L et al. (2017) Surveilling the Potential for Precision Medicine-driven PD-1/PD-L1-targeted Therapy in HNSCC. J Cancer 8:332-344|
|Birkeland, Andrew C; Foltin, Susan K; Michmerhuizen, Nicole L et al. (2017) Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma. Oral Oncol 68:5-8|
|Walline, Heather M; Goudsmit, Christine M; McHugh, Jonathan B et al. (2017) Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell lines. Head Neck 39:840-852|
|Walline, Heather M; Carey, Thomas E; Goudsmit, Christine M et al. (2017) High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV. Mol Cancer Res 15:179-188|
|Chen, Yan; Zhou, Quan; Li, Xue et al. (2017) Ultrasmall Paramagnetic Iron Oxide Nanoprobe Targeting Epidermal Growth Factor Receptor for In Vivo Magnetic Resonance Imaging of Hepatocellular Carcinoma. Bioconjug Chem 28:2794-2803|
Showing the most recent 10 out of 1355 publications